Comprehensive Stock Comparison
Compare LiveRamp Holdings, Inc. (RAMP) vs Cellebrite DI Ltd. (CLBT) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | CLBT | 18.6% revenue growth vs RAMP's 13.0% |
| Value | RAMP | Lower P/E (12.1x vs 36.3x) |
| Quality / Margins | CLBT | 16.5% net margin vs RAMP's 8.6% |
| Stability / Safety | CLBT | Beta 0.83 vs RAMP's 1.08 |
| Dividends | Tie | Neither pays a meaningful dividend |
| Momentum (1Y) | RAMP | -9.1% vs CLBT's -28.1% |
| Efficiency (ROA) | CLBT | 8.3% ROA vs RAMP's 5.7%, ROIC 18.5% vs 0.7% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
LiveRamp operates a data connectivity platform that helps companies securely connect and activate their customer data across marketing and analytics applications. It generates revenue primarily through subscription fees for its data connectivity services — including identity resolution, data marketplace access, and data clean room solutions — with enterprise clients across retail, financial services, and consumer packaged goods sectors. The company's key advantage is its neutral, privacy-focused infrastructure that enables secure data collaboration without direct data sharing, creating a trusted ecosystem that's difficult for competitors to replicate.
Cellebrite provides digital intelligence solutions for legally sanctioned investigations by law enforcement and government agencies. It generates revenue primarily from software licenses and maintenance fees for its forensic data extraction and analysis platforms — including its Universal Forensic Extraction Device and DI platform — which help investigators access and analyze digital evidence from locked, encrypted, or deleted sources. The company's key advantage is its deep technical expertise in overcoming device security barriers and its established relationships with government agencies worldwide, creating high switching costs in a specialized, regulated market.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
CLBT leads in 4 of 6 categories (Financial Metrics, Profitability & Efficiency). RAMP leads in 1 (Valuation Metrics). 1 tied.
Financial Metrics (TTM)
RAMP is the larger business by revenue, generating $796M annually — 1.7x CLBT's $476M. CLBT is the more profitable business, keeping 16.5% of every revenue dollar as net income compared to RAMP's 8.6%. On growth, CLBT holds the edge at +18.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | RAMPLiveRamp Holdings… | CLBTCellebrite DI Ltd. |
|---|---|---|
| RevenueTrailing 12 months | $796M | $476M |
| EBITDAEarnings before interest/tax | $71M | $78M |
| Net IncomeAfter-tax profit | $69M | $78M |
| Free Cash FlowCash after capex | $169M | $160M |
| Gross MarginGross profit ÷ Revenue | +70.4% | +84.2% |
| Operating MarginEBIT ÷ Revenue | +7.1% | +14.0% |
| Net MarginNet income ÷ Revenue | +8.6% | +16.5% |
| FCF MarginFCF ÷ Revenue | +21.3% | +33.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.6% | +18.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.6% | +2.7% |
Valuation Metrics
On an enterprise value basis, CLBT's 40.3x EV/EBITDA is more attractive than RAMP's 59.2x.
| Metric | RAMPLiveRamp Holdings… | CLBTCellebrite DI Ltd. |
|---|---|---|
| Market CapShares × price | $1.7B | $3.3B |
| Enterprise ValueMkt cap + debt − cash | $1.3B | $3.2B |
| Trailing P/EPrice ÷ TTM EPS | -2245.45x | 43.03x |
| Forward P/EPrice ÷ next-FY EPS est. | 12.10x | 36.25x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.73x |
| EV / EBITDAEnterprise value multiple | 59.18x | 40.33x |
| Price / SalesMarket cap ÷ Revenue | 2.30x | 6.86x |
| Price / BookPrice ÷ Book value/share | 1.93x | 6.88x |
| Price / FCFMarket cap ÷ FCF | 11.09x | 20.34x |
Profitability & Efficiency
CLBT delivers a 16.2% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $7 for RAMP. RAMP carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to CLBT's 0.05x. On the Piotroski fundamental quality scale (0–9), RAMP scores 5/9 vs CLBT's 4/9, reflecting solid financial health.
| Metric | RAMPLiveRamp Holdings… | CLBTCellebrite DI Ltd. |
|---|---|---|
| ROE (TTM)Return on equity | +7.1% | +16.2% |
| ROA (TTM)Return on assets | +5.7% | +8.3% |
| ROICReturn on invested capital | +0.7% | +18.5% |
| ROCEReturn on capital employed | +0.5% | +13.8% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 |
| Debt / EquityFinancial leverage | 0.04x | 0.05x |
| Net DebtTotal debt minus cash | -$377M | -$102M |
| Cash & Equiv.Liquid assets | $413M | $124M |
| Total DebtShort + long-term debt | $36M | $23M |
| Interest CoverageEBIT ÷ Interest expense | 31.98x | — |
Total Returns (with DRIP)
A $10,000 investment in CLBT five years ago would be worth $12,549 today (with dividends reinvested), compared to $4,114 for RAMP. Over the past 12 months, RAMP leads with a -9.1% total return vs CLBT's -28.1%. The 3-year compound annual growth rate (CAGR) favors CLBT at 29.4% vs RAMP's 4.8% — a key indicator of consistent wealth creation.
| Metric | RAMPLiveRamp Holdings… | CLBTCellebrite DI Ltd. |
|---|---|---|
| YTD ReturnYear-to-date | -0.9% | -25.2% |
| 1-Year ReturnPast 12 months | -9.1% | -28.1% |
| 3-Year ReturnCumulative with dividends | +15.0% | +116.9% |
| 5-Year ReturnCumulative with dividends | -58.9% | +25.5% |
| 10-Year ReturnCumulative with dividends | +31.0% | +38.1% |
| CAGR (3Y)Annualised 3-year return | +4.8% | +29.4% |
Risk & Volatility
CLBT is the less volatile stock with a 0.83 beta — it tends to amplify market swings less than RAMP's 1.08 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. RAMP currently trades 77.2% from its 52-week high vs CLBT's 64.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | RAMPLiveRamp Holdings… | CLBTCellebrite DI Ltd. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.08x | 0.83x |
| 52-Week HighHighest price in past year | $35.20 | $20.86 |
| 52-Week LowLowest price in past year | $21.71 | $11.76 |
| % of 52W HighCurrent price vs 52-week peak | +77.2% | +64.0% |
| RSI (14)Momentum oscillator 0–100 | 62.3 | 43.9 |
| Avg Volume (50D)Average daily shares traded | 519K | 1.3M |
Analyst Outlook
Wall Street rates RAMP as "Buy" and CLBT as "Buy". Consensus price targets imply 61.9% upside for RAMP (target: $44) vs 54.9% for CLBT (target: $21).
| Metric | RAMPLiveRamp Holdings… | CLBTCellebrite DI Ltd. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $44.00 | $20.67 |
| # AnalystsCovering analysts | 12 | 8 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 0 | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +5.9% | 0.0% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Dec 20 | Feb 26 | Change |
|---|---|---|---|
| LiveRamp Holdings, … (RAMP) | 100 | 42.4 | -57.6% |
| Cellebrite DI Ltd. (CLBT) | 102.48 | 154.24 | +50.5% |
Cellebrite DI Ltd. (CLBT) returned +25% over 5 years vs LiveRamp Holdings, … (RAMP)'s -59%. A $10,000 investment in CLBT 5 years ago would be worth $12,549 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| LiveRamp Holdings, … (RAMP) | $850M | $746M | -12.3% |
| Cellebrite DI Ltd. (CLBT) | $172M | $476M | +176.8% |
LiveRamp Holdings, Inc.'s revenue grew from $850M (2016) to $746M (2025) — a -1.4% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| LiveRamp Holdings, … (RAMP) | 0.8% | -0.1% | -113.8% |
| Cellebrite DI Ltd. (CLBT) | -1.1% | 16.5% | +1608.5% |
LiveRamp Holdings, Inc.'s net margin went from 1% (2016) to -0% (2025).
Chart 4P/E Ratio History — 7 Years
| Stock | 2018 | 2025 | Change |
|---|---|---|---|
| LiveRamp Holdings, … (RAMP) | 133.2 | 178.6 | +34.1% |
| Cellebrite DI Ltd. (CLBT) | 340.8 | 58.2 | -82.9% |
LiveRamp Holdings, Inc. has traded in a 4x–179x P/E range over 3 years; current trailing P/E is ~-2245x. Cellebrite DI Ltd. has traded in a 7x–341x P/E range over 4 years; current trailing P/E is ~43x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| LiveRamp Holdings, … (RAMP) | 0.09 | -0.01 | -113.4% |
| Cellebrite DI Ltd. (CLBT) | -0.01 | 0.31 | +3200.0% |
LiveRamp Holdings, Inc.'s EPS grew from $0.09 (2016) to $-0.01 (2025) — a NaN% CAGR.
Chart 6Free Cash Flow — 5 Years
LiveRamp Holdings, Inc. generated $155M FCF in 2025 (+780% vs 2021). Cellebrite DI Ltd. generated $160M FCF in 2025 (+474% vs 2021).
RAMP vs CLBT: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is RAMP or CLBT a better buy right now?
Cellebrite DI Ltd. (CLBT) offers the better valuation at 43.0x trailing P/E (36.3x forward), making it the more compelling value choice. Analysts rate LiveRamp Holdings, Inc. (RAMP) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RAMP or CLBT?
On forward P/E, LiveRamp Holdings, Inc. is actually cheaper at 12.1x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — RAMP or CLBT?
Over the past 5 years, Cellebrite DI Ltd. (CLBT) delivered a total return of +25.5%, compared to -58.9% for LiveRamp Holdings, Inc. (RAMP). A $10,000 investment in CLBT five years ago would be worth approximately $13K today (assuming dividends reinvested). Over 10 years, the gap is even starker: CLBT returned +38.1% versus RAMP's +31.0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RAMP or CLBT?
By beta (market sensitivity over 5 years), Cellebrite DI Ltd. (CLBT) is the lower-risk stock at 0.83β versus LiveRamp Holdings, Inc.'s 1.08β — meaning RAMP is approximately 31% more volatile than CLBT relative to the S&P 500. On balance sheet safety, LiveRamp Holdings, Inc. (RAMP) carries a lower debt/equity ratio of 4% versus 5% for Cellebrite DI Ltd. — giving it more financial flexibility in a downturn.
05Which has better profit margins — RAMP or CLBT?
Cellebrite DI Ltd. (CLBT) is the more profitable company, earning 16.5% net margin versus -0.1% for LiveRamp Holdings, Inc. — meaning it keeps 16.5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CLBT leads at 14.0% versus 0.7% for RAMP. At the gross margin level — before operating expenses — CLBT leads at 84.2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is RAMP or CLBT more undervalued right now?
On forward earnings alone, LiveRamp Holdings, Inc. (RAMP) trades at 12.1x forward P/E versus 36.3x for Cellebrite DI Ltd. — 24.2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for RAMP: 61.9% to $44.00.
07Which pays a better dividend — RAMP or CLBT?
None of the stocks in this comparison currently pay a material dividend. All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is RAMP or CLBT better for a retirement portfolio?
For long-horizon retirement investors, Cellebrite DI Ltd. (CLBT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.83)). Both have compounded well over 10 years (CLBT: +38.1%, RAMP: +31.0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between RAMP and CLBT?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.